<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04544566</url>
  </required_header>
  <id_info>
    <org_study_id>CP319</org_study_id>
    <nct_id>NCT04544566</nct_id>
  </id_info>
  <brief_title>A Clinical Pilot Study of Newly Developed Ostomy Tapes and How They Adhere to the Skin</brief_title>
  <official_title>A Clinical Pilot Study of Newly Developed Ostomy Tapes and How They Adhere to the Skin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An investigation of non-CE marked stoma tape products. This investigation is a randomised,&#xD;
      open-label, comparative, cross-over study, with three test periods. In total, 12 subjects&#xD;
      will be included and randomised.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The test products are non-CE marked stoma tape products. This investigation is a randomised,&#xD;
      open-label, comparative, cross-over study, with three test periods. In total, 12 subjects&#xD;
      will be included and randomised.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 7, 2020</start_date>
  <completion_date type="Actual">August 21, 2020</completion_date>
  <primary_completion_date type="Actual">August 21, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Adherent Area Measured by Photo of Used Tape</measure>
    <time_frame>Tapestrips per test product were removed from the baseplate at each product change and saved for the next site visit every 7-9 days for evaluation</time_frame>
    <description>The adherent area (cm2) measured per baseplate change after use shows how effectively the ostomy tape adheres to the skin. After removal of the ostomy tape, a photo of the tape was taken. The adherent area was measured from the photo and an image analysing program.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Erythema Measured After Each Treatment Period by Spectrophotometric Method</measure>
    <time_frame>The measurements were carried out after 7-9 days of treatment with the test tape</time_frame>
    <description>A change in the surface skin colour is known to be related to a change in the blood flow. This can be measured non-invasively with a spectrophotometric instrument (Derma-spectrophotometer, Cortex Technology A/S, Hadsund) where redness of the skin is measured. The measurement of erythema is based on an active color detecting chip. Illumination is provided by two high intensity white LEDs. The spectrophotometer accommodates the color sensor, filters, optics and light source. Light is provided by two high intensity with LEDs and a unique feature is the guiding light, which illuminates the target during the positioning of the device. The LEDs illuminates the target area and the skin color measurement is performed. The measurements performed with the spectrophotometric instrument do not have units. But the measures are used for the estimation of the level of the redness (hemoglobin) in the skin. The higher the value, the more pigment in the skin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Erythema Measured After Tape Removal by Photos</measure>
    <time_frame>The measurements were carried out after 7-9 days of treatment with the test tape</time_frame>
    <description>A change in the surface skin colour is known to be related to a change in the blood flow. This can be measured non-invasively with a spectrophotometric instrument (Derma-spectrophotometer, Cortex Technology A/S, Hadsund) where both the redness and the colour of the skin are measured. Furthermore, visual assessments of photos have been used in several exploratory clinical investigations by Coloplast A/S to explore how adhesives affect the skin. The visual assessment is conducted by trained personnel and is a valuable tool for assessing newly developed adhesives and their impact on skin in the early development phases.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feeling of Security</measure>
    <time_frame>The evaluation was carried out after 7-9 days of treatment with the test tape</time_frame>
    <description>Subjects will be asked how they rate feeling of security (&quot;How was the feeling of security?) on a five point scale, when wearing the tape; 1. Very Poor, 2. Poor, 3. Acceptable, 4. Good, 5. Very Good.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adhesion of Tape</measure>
    <time_frame>The evaluation was carried out after 7-9 days of treatment with the test tape</time_frame>
    <description>Subjects will be asked how they perceive the immediate adhesion to the skin (&quot;how was the immediate adhesion to the skin?) and rate adhesion on a five-point scale: 1. Very poor, 2. Poor, 3. Acceptable, 4. Good, 5. Very good.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comfort</measure>
    <time_frame>The evaluation was carried out after 7-9 days of treatment with the test tape</time_frame>
    <description>Subjects will be asked how they perceived the comfort of the tape (&quot;How comfortable was the tape to wear?&quot;) and rate comfort on a 5-pont scale; 1. very discomfortable, 2. Discomfortable, 3. Acceptable, 4. Comfortable, 5. Very comfortable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skin Issues in the Area Covered by the Tape</measure>
    <time_frame>The evaluation was carried out after 7-9 days of treatment with the test tape</time_frame>
    <description>Subjects will be asked if they had any skin-related complications in the area covered by the tape (yes, no).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>27 days</time_frame>
    <description>All Adverse Events are captured and documented throughout the study.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Stoma Site Leakage</condition>
  <arm_group>
    <arm_group_label>Test product A new adhesive material</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test product B new adhesion material</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The comparator product is Brava Elastic tape which is already on the market and will be used within the in-tended use in this clinical investigation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test product A</intervention_name>
    <description>one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
    <arm_group_label>Comparator</arm_group_label>
    <arm_group_label>Test product A new adhesive material</arm_group_label>
    <arm_group_label>Test product B new adhesion material</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test product B</intervention_name>
    <description>one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
    <arm_group_label>Comparator</arm_group_label>
    <arm_group_label>Test product A new adhesive material</arm_group_label>
    <arm_group_label>Test product B new adhesion material</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Comparator</intervention_name>
    <description>Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
    <arm_group_label>Comparator</arm_group_label>
    <arm_group_label>Test product A new adhesive material</arm_group_label>
    <arm_group_label>Test product B new adhesion material</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Has given written informed consent&#xD;
&#xD;
          -  Be at least 18 years of age and have full legal capacity&#xD;
&#xD;
          -  Have had a stoma for more than Â½ year&#xD;
&#xD;
          -  Have intact skin on the area used in the study (Assessed by investigator, see Appendix&#xD;
             1).&#xD;
&#xD;
          -  Willing to change baseplate every second day or less frequent&#xD;
&#xD;
          -  Willing to avoid using Concave baseplate during the study.&#xD;
&#xD;
          -  Willing to avoid the use of barrier creams or similar that affect the skin/adhesive&#xD;
             interface under the tape.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently receiving or have within the past 2 months received radio-and/or&#xD;
             chemotherapy&#xD;
&#xD;
          -  Currently receiving or have within the past month received topical steroid treatment&#xD;
             in the peristomal skin area or systemic steroid (tablet(injection) treatment&#xD;
&#xD;
          -  Is pregnant or breastfeeding&#xD;
&#xD;
          -  Having dermatological problems in the peristomal area (assessed by investigator)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tonny Karlsmark, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg hospital, Dermato-Venerologisk afdeling.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen NV</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 26, 2020</study_first_submitted>
  <study_first_submitted_qc>September 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2020</study_first_posted>
  <results_first_submitted>December 11, 2020</results_first_submitted>
  <results_first_submitted_qc>April 13, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 6, 2021</results_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 11, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/66/NCT04544566/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>All subjects that met the inclusion and exclusion criteria was randomised to one of six treatment arms. Each arm examined the Comparator Tape and the two Test Tapes in various orders.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Test Tape A, Test Tape B, and Then Comparator Tape</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="P2">
          <title>Test Tape A, Comparator Tape and Then Test Tape B</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="P3">
          <title>Comparator Tape, Test Tape A and Then Test Tape B</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="P4">
          <title>Comparator Tape, Test Tape B and Then Test Tape A</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="P5">
          <title>Test Tape B, Comparator Tape and Then Test Tape A</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="P6">
          <title>Test Tape B, Test Tape A and Then Comparator Tape</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>One subject from treatment arm 6 did not complete the questionnaires related to secondary endpoints</population>
      <group_list>
        <group group_id="B1">
          <title>Test Tape A, Test Tape B, and Then Comparator Tape</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="B2">
          <title>Test Tape A, Comparator Tape and Then Test Tape B</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="B3">
          <title>Comparator Tape, Test Tape A and Then Test Tape B</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="B4">
          <title>Comparator Tape, Test Tape B and Then Test Tape A</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="B5">
          <title>Test Tape B, Comparator Tape and Then Test Tape A</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="B6">
          <title>Test Tape B, Test Tape A and Then Comparator Tape</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the in-tended use in this clinical investigation.</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
            <count group_id="B2" value="2"/>
            <count group_id="B3" value="2"/>
            <count group_id="B4" value="2"/>
            <count group_id="B5" value="2"/>
            <count group_id="B6" value="2"/>
            <count group_id="B7" value="12"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2"/>
                    <count group_id="B2" value="2"/>
                    <count group_id="B3" value="2"/>
                    <count group_id="B4" value="2"/>
                    <count group_id="B5" value="2"/>
                    <count group_id="B6" value="2"/>
                    <count group_id="B7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2"/>
                    <count group_id="B2" value="2"/>
                    <count group_id="B3" value="2"/>
                    <count group_id="B4" value="2"/>
                    <count group_id="B5" value="2"/>
                    <count group_id="B6" value="2"/>
                    <count group_id="B7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.5" spread="26.2"/>
                    <measurement group_id="B2" value="71" spread="0"/>
                    <measurement group_id="B3" value="71.5" spread="6.4"/>
                    <measurement group_id="B4" value="42.5" spread="30.4"/>
                    <measurement group_id="B5" value="63" spread="19.8"/>
                    <measurement group_id="B6" value="66" spread="0"/>
                    <measurement group_id="B7" value="61.1" spread="17.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2"/>
                    <count group_id="B2" value="2"/>
                    <count group_id="B3" value="2"/>
                    <count group_id="B4" value="2"/>
                    <count group_id="B5" value="2"/>
                    <count group_id="B6" value="2"/>
                    <count group_id="B7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                    <count group_id="B6" value="0"/>
                    <count group_id="B7" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Denmark</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2"/>
                    <count group_id="B2" value="2"/>
                    <count group_id="B3" value="2"/>
                    <count group_id="B4" value="2"/>
                    <count group_id="B5" value="2"/>
                    <count group_id="B6" value="2"/>
                    <count group_id="B7" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Adherent Area Measured by Photo of Used Tape</title>
        <description>The adherent area (cm2) measured per baseplate change after use shows how effectively the ostomy tape adheres to the skin. After removal of the ostomy tape, a photo of the tape was taken. The adherent area was measured from the photo and an image analysing program.</description>
        <time_frame>Tapestrips per test product were removed from the baseplate at each product change and saved for the next site visit every 7-9 days for evaluation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Test Product A New Adhesive Material</title>
            <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O2">
            <title>Test Product B New Adhesion Material</title>
            <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O3">
            <title>Comparator</title>
            <description>The comparator product is Brava Elastic tape which is already on the market and will be used within the intended use in this clinical investigation.&#xD;
Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Adherent Area Measured by Photo of Used Tape</title>
          <description>The adherent area (cm2) measured per baseplate change after use shows how effectively the ostomy tape adheres to the skin. After removal of the ostomy tape, a photo of the tape was taken. The adherent area was measured from the photo and an image analysing program.</description>
          <units>Cm2</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.54" spread="1.23"/>
                    <measurement group_id="O2" value="51.61" spread="1.24"/>
                    <measurement group_id="O3" value="52.94" spread="1.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Erythema Measured After Each Treatment Period by Spectrophotometric Method</title>
        <description>A change in the surface skin colour is known to be related to a change in the blood flow. This can be measured non-invasively with a spectrophotometric instrument (Derma-spectrophotometer, Cortex Technology A/S, Hadsund) where redness of the skin is measured. The measurement of erythema is based on an active color detecting chip. Illumination is provided by two high intensity white LEDs. The spectrophotometer accommodates the color sensor, filters, optics and light source. Light is provided by two high intensity with LEDs and a unique feature is the guiding light, which illuminates the target during the positioning of the device. The LEDs illuminates the target area and the skin color measurement is performed. The measurements performed with the spectrophotometric instrument do not have units. But the measures are used for the estimation of the level of the redness (hemoglobin) in the skin. The higher the value, the more pigment in the skin.</description>
        <time_frame>The measurements were carried out after 7-9 days of treatment with the test tape</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Test Product A New Adhesive Material</title>
            <description>Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O2">
            <title>Test Product B New Adhesion Material</title>
            <description>Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O3">
            <title>Comparator</title>
            <description>Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
        </group_list>
        <measure>
          <title>Erythema Measured After Each Treatment Period by Spectrophotometric Method</title>
          <description>A change in the surface skin colour is known to be related to a change in the blood flow. This can be measured non-invasively with a spectrophotometric instrument (Derma-spectrophotometer, Cortex Technology A/S, Hadsund) where redness of the skin is measured. The measurement of erythema is based on an active color detecting chip. Illumination is provided by two high intensity white LEDs. The spectrophotometer accommodates the color sensor, filters, optics and light source. Light is provided by two high intensity with LEDs and a unique feature is the guiding light, which illuminates the target during the positioning of the device. The LEDs illuminates the target area and the skin color measurement is performed. The measurements performed with the spectrophotometric instrument do not have units. But the measures are used for the estimation of the level of the redness (hemoglobin) in the skin. The higher the value, the more pigment in the skin.</description>
          <units>Unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1" spread="2.6"/>
                    <measurement group_id="O2" value="10.0" spread="3.0"/>
                    <measurement group_id="O3" value="11.0" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Erythema Measured After Tape Removal by Photos</title>
        <description>A change in the surface skin colour is known to be related to a change in the blood flow. This can be measured non-invasively with a spectrophotometric instrument (Derma-spectrophotometer, Cortex Technology A/S, Hadsund) where both the redness and the colour of the skin are measured. Furthermore, visual assessments of photos have been used in several exploratory clinical investigations by Coloplast A/S to explore how adhesives affect the skin. The visual assessment is conducted by trained personnel and is a valuable tool for assessing newly developed adhesives and their impact on skin in the early development phases.</description>
        <time_frame>The measurements were carried out after 7-9 days of treatment with the test tape</time_frame>
        <population>One subject from treatment-arm 6 is missing from the analysis as the photo material of the subject was insufficient for assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Test Product A New Adhesive Material</title>
            <description>Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O2">
            <title>Test Product B New Adhesion Material</title>
            <description>Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O3">
            <title>Comparator</title>
            <description>Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
        </group_list>
        <measure>
          <title>Erythema Measured After Tape Removal by Photos</title>
          <description>A change in the surface skin colour is known to be related to a change in the blood flow. This can be measured non-invasively with a spectrophotometric instrument (Derma-spectrophotometer, Cortex Technology A/S, Hadsund) where both the redness and the colour of the skin are measured. Furthermore, visual assessments of photos have been used in several exploratory clinical investigations by Coloplast A/S to explore how adhesives affect the skin. The visual assessment is conducted by trained personnel and is a valuable tool for assessing newly developed adhesives and their impact on skin in the early development phases.</description>
          <population>One subject from treatment-arm 6 is missing from the analysis as the photo material of the subject was insufficient for assessment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Lowest degree of skin reaction</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Middle degree of skin reaction</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Highest degree of skin reaction</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Feeling of Security</title>
        <description>Subjects will be asked how they rate feeling of security (&quot;How was the feeling of security?) on a five point scale, when wearing the tape; 1. Very Poor, 2. Poor, 3. Acceptable, 4. Good, 5. Very Good.</description>
        <time_frame>The evaluation was carried out after 7-9 days of treatment with the test tape</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Test Product A New Adhesive Material</title>
            <description>Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O2">
            <title>Test Product B New Adhesion Material</title>
            <description>Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O3">
            <title>Comparator</title>
            <description>Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
        </group_list>
        <measure>
          <title>Feeling of Security</title>
          <description>Subjects will be asked how they rate feeling of security (&quot;How was the feeling of security?) on a five point scale, when wearing the tape; 1. Very Poor, 2. Poor, 3. Acceptable, 4. Good, 5. Very Good.</description>
          <units>Product change</units>
          <param>Count of Units</param>
          <units_analyzed>Product change</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Product change</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very poor</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Poor</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Acceptable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Good</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very good</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adhesion of Tape</title>
        <description>Subjects will be asked how they perceive the immediate adhesion to the skin (&quot;how was the immediate adhesion to the skin?) and rate adhesion on a five-point scale: 1. Very poor, 2. Poor, 3. Acceptable, 4. Good, 5. Very good.</description>
        <time_frame>The evaluation was carried out after 7-9 days of treatment with the test tape</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Test Product A New Adhesive Material</title>
            <description>Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O2">
            <title>Test Product B New Adhesion Material</title>
            <description>Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O3">
            <title>Comparator</title>
            <description>Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
        </group_list>
        <measure>
          <title>Adhesion of Tape</title>
          <description>Subjects will be asked how they perceive the immediate adhesion to the skin (&quot;how was the immediate adhesion to the skin?) and rate adhesion on a five-point scale: 1. Very poor, 2. Poor, 3. Acceptable, 4. Good, 5. Very good.</description>
          <units>Product change</units>
          <param>Count of Units</param>
          <units_analyzed>Product change</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Product change</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very poor</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Poor</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Acceptable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Good</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very good</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comfort</title>
        <description>Subjects will be asked how they perceived the comfort of the tape (&quot;How comfortable was the tape to wear?&quot;) and rate comfort on a 5-pont scale; 1. very discomfortable, 2. Discomfortable, 3. Acceptable, 4. Comfortable, 5. Very comfortable.</description>
        <time_frame>The evaluation was carried out after 7-9 days of treatment with the test tape</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Test Product A New Adhesive Material</title>
            <description>Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O2">
            <title>Test Product B New Adhesion Material</title>
            <description>Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O3">
            <title>Comparator</title>
            <description>Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort</title>
          <description>Subjects will be asked how they perceived the comfort of the tape (&quot;How comfortable was the tape to wear?&quot;) and rate comfort on a 5-pont scale; 1. very discomfortable, 2. Discomfortable, 3. Acceptable, 4. Comfortable, 5. Very comfortable.</description>
          <units>Product change</units>
          <param>Count of Units</param>
          <units_analyzed>Product change</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Product change</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very discomfortable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Discomfortable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Acceptable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Comfortable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very comfortable</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Skin Issues in the Area Covered by the Tape</title>
        <description>Subjects will be asked if they had any skin-related complications in the area covered by the tape (yes, no).</description>
        <time_frame>The evaluation was carried out after 7-9 days of treatment with the test tape</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Test Product A New Adhesive Material</title>
            <description>Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O2">
            <title>Test Product B New Adhesion Material</title>
            <description>Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O3">
            <title>Comparator</title>
            <description>Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
          </group>
        </group_list>
        <measure>
          <title>Skin Issues in the Area Covered by the Tape</title>
          <description>Subjects will be asked if they had any skin-related complications in the area covered by the tape (yes, no).</description>
          <units>Product change</units>
          <param>Count of Units</param>
          <units_analyzed>Product change</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Product change</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Complications where tape was applied - Yes</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Complications were tape was applied- No</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="36"/>
                    <measurement group_id="O3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Events</title>
        <description>All Adverse Events are captured and documented throughout the study.</description>
        <time_frame>27 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Test Tape A</title>
            <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material was applied to the baseplate and the subjects peristomal skin</description>
          </group>
          <group group_id="O2">
            <title>Test Tape B</title>
            <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product B: one new adhesive material was applied to the baseplate and the subjects peristomal skin.</description>
          </group>
          <group group_id="O3">
            <title>Comparator Tape</title>
            <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
The comparator product is Brava Elastic tape which is a CE marked product already on the market and applied to the baseplate and the subjects peristomal skin. The product was used within the intended use in this clinical investigation.</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events</title>
          <description>All Adverse Events are captured and documented throughout the study.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected throughout the study period for a maximum of 27 days. If subject had on-going SAEs at termination, they were followed until the event was solved or until the subject could no longer be followed (lost to follow up). Subjects without SAEs or with terminated SAEs were not followed-up upon after the final termination visit.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Test Product A New Adhesive Material</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
        </group>
        <group group_id="E2">
          <title>Test Product B New Adhesion Material</title>
          <description>The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.&#xD;
Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
        </group>
        <group group_id="E3">
          <title>Comparator</title>
          <description>The comparator product is Brava Elastic tape which is already on the market and will be used within the in-tended use in this clinical investigation.&#xD;
Test product A: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Test product B: one new adhesive material which is applied to the baseplate and the subjects peristomal skin&#xD;
Comparator: Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Non serious adverse event</sub_title>
                <description>Parodontitis Spicalis</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Non serious adverse event</sub_title>
                <description>Erosion of peristomal skin</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>One subject missed completing questionnaire related to secondary end points for Test Tape A and Comparator Tape and one subject was included in the study despite treatment with steroid cream of pyoderma ulcers. The treatment was close to being completed and was assessed by investigator as a deviation that had no impact on the rights, safety and well-being of the subject or that could impact the scientific outcome of the investigation.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Head of Scientific Affairs</name_or_title>
      <organization>Coloplast A/S</organization>
      <phone>+45 4911 1111</phone>
      <email>clinicaltrialsgovSA@coloplast.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

